Access to Essential Medicines in Pakistan: Policy and Health Systems Research Concerns

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Zaidi, Shehla ^a   Bigdeli, Maryam ^b   Aleem, Noureen ^a   Rashidian, Arash ^c  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL DRUG;

ACCESS TO ESSENTIAL MEDICINE; ARTICLE; DRUG APPROVAL; DRUG COST; EXPLORATORY RESEARCH; FUNDING; HEALTH CARE CONCEPTS; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; INAPPROPRIATE PRESCRIBING; PAKISTAN; QUALITY CONTROL;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH POLICY; HUMANS; MEDICINE; PAKISTAN; PHARMACEUTICAL PREPARATIONS;

EID: 84878056608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063515     Document Type: Article

References (56)

1. World Health Organization (2007). Regional Office for Eastern Mediterranean Technical discussion on Medicine prices and access to medicines in the Eastern Mediterranean Region. World Health Organization. Regional Office for the Eastern Mediterranean.
2. World Health Organization (2004). The World Medicines Situation. World Health Organization. Available: http://www.emro.who.int/edb/media/pdf/EMRC54TECHDISC01en.pdf. Accessed 17 Feb 2011.
3. World Health Organization (2007). Everybody's Business: Strengthening Health System to Improve Health Outcome, WHO's Framework for Action. Geneva WHO. Available: www.who.int/healthsystems/strategy/everybodys_business.pdf. Accessed 21 May 2011.
4. Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, et al. (2012). Access to medicines from a health system perspective. Health Policy and Planning. doi: 10.1093/heapol/czs108.
5. Ranson K, Law TJ, Bennett S, (2010) Establishing health systems financing research priorities in developing countries using a participatory methodology. SocSci Med 70: 1933-1942.
6. World Health Organization (2011). Regional Health Systems Observatory- EMRO. World Health Organization. Available: http://gis.emro.who.int/HealthSystemObservatory/PDF/Pakistan/Exec%20summary.pdf Accessed 22 April 2011.
7. World Health Organization (2004) Equitable access to essential medicines: a framework for collective action. Available: http://whqlibdoc.who.int/hq/2004/WHO_EDM_2004.4.pdf. Accessed 15 December 2012.
8. MOH (2007). National Essential Medicine List of Pakistan. Ministry of Health. Government of Pakistan. Available: http://apps.who.int/medicinedocs/documents/s17119e/s17119e.pdf. Accessed 21 December 2012.
9. Network (2002). EDSP Baseline Survey Report. Prescription, dispensing and storage practices in the provinces of NWFP, Baluchistan and Punjab in collaboration with Network for Consumer Protection.
10. MOH (1976). Drug Act 1976. Ministry of Health Government of Pakistan Islamabad. Available: www.pmdc.org.pk/LinkClick.aspx?fileticket.tabid = 292&mid. Accessed 24 June 2011.
11. Das N, Khan AN, Badini ZA, Baloch H, Parkash J, (2001) Prescribing practices of consultants at Karachi, Pakistan. J Pak Med Assoc 51: 74-77.
12. Hafeez A, Kiani AG, Din Su, Muhammad W, Butt K, et al. (2004) Prescription and dispensing practices in public sector health facilities in Pakistan: survey report. J Pak Med Assoc 54: 187-191.
13. Siddiqi S, Hamid S, Rafique G, Chaudhry SA, Ali N, et al. (2002) Prescription practices of public and private health care providers in Attock District of Pakistan. Int J Health Plan Manage 17: 23-40.
14. Nizami SQ, Khan IA, Bhutta ZA, (1996) Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan. SocSci Med 42: 1133-1139.
15. Shehzadi R, Irfan M, Zohra T, Khan JA, Hussain SF, (2005) Knowledge regarding management of tuberculosis among general practitioners in northern areas of Pakistan. J Pak Med Assoc 55: 174-176.
16. Ahmed Z, Tahir A, Sohail A. (2005) High rate of prescription of antibiotics in treatment of upper respiratory infections. Pakistan Armed Forces Medical Journal Issue Number 1.
17. Jafar TH, Jessani S, Jafary FH, Ishaq M, Orakzai R, et al. (2005) General practitioners' approach to hypertension in urban Pakistan: disturbing trends in practice. Circulation 111: 1278-1283.
18. Najmi MH, Hafiz RA, Khan I, Fazli FR, (1998) Prescribing practices: an overview of three teaching hospitals in Pakistan. J Pak Med Assoc 48: 73-77.
19. Shiwani MH, (2006) Quest of prescribing practice in Pakistan. J Pak Med Assoc 56: 249-250.
20. Rabbani F, Cheema FH, Talati N, Siddiqui S, Syed S, et al. (2001) Behind the counter: pharmacies and dispensing patterns of pharmacy attendants in Karachi. J Pak Med Assoc 51: 149-153.
21. Butt ZA, Gilani AH, Nanan D, Sheikh AL, White F, (2005) Quality of pharmacies in Pakistan: a cross-sectional survey. Int J Qual Health Care 17: 307-313.
22. Haider S, Thaver IH, (1995) Self medication or self care: implication for primary health care strategies. J Pak Med Assoc 45: 297-298.
23. Sturm AW, Van der Pol R, Smits AJ, van Hellemondt FM, Mouton SW, et al. (1997) Over-the-counter availability of antimicrobial agents, self-medication and patterns of resistance in Karachi, Pakistan. J Antimicrob. Chemother 39: 543-547.
24. Network for Consumer Protection. (2006) Prices, availability and affordability of medicines in Pakistan. Available: www.haiweb.org/medicineprices/surveys/./survey_report.pdf. Accessed March 11 2011.
25. MOH. (2010) Pharmaceutical Country Profile. Pakistan. Ministry of Health, Government of Pakistan Islamabad. Available: www.who.int/medicines/areas/coordination/pakistan.pdf. Accessed 14 July 2011.
26. Nishtar S, (2006) Pharmaceuticals-strategic considerations in health reforms in Pakistan. J Pak Med Assoc, 56 (12Suppl 4): S100-11.
27. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R, (2009) Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 373: 240-249.
28. Mendis S, Fukino K, Cameron A, Laing R, Filipe A, et al. (2007) The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 85: 279-88.
29. NHA. (2009) National Health Accounts for Pakistan, Federal Bureau of Statistics, Islamabad. Available: http://www.statpak.gov.pk/depts/fbs/publications/publications.html. Accessed 12 June 2011.
30. World Bank. (2010) Delivering better health services to Pakistan's poor. The World Bank Islamabad. Available: https://openknowledge.worldbank.org/handle/10986/12369. Accessed 12 August 2011.
31. WHO. (2002) Proceedings of the twentieth anniversary symposium. ATC/DDD classification. WHO Collaborating Centre for Drug Statistics Methodology. WHO Drug Information. Available http://apps.who.int/medicinedocs/en/d/Js4951e/5.html. Accessed 11 April 2011.
32. CIET. (2002) Social audit of governance and delivery of public services. Baseline survey Community intervention trials. Available: www.ciet.org/_documents/2006224174624.pdf. Accessed 18 Jan 2011.
33. Zaidi S, Shafqat S, Sayeed A, Khowaja L. (2010) Landscaping Health Financing Works in Pakistan: Report. Pakistan Health Economics Network, Health Services Academy, Islamabad. Available: www.hsa.edu.pk/the-academy/the-academy-data/./he-landscaping.p. Accessed: 19 August 2011.
34. TRF. (2011) Situation Analysis for Post Devolution Health Sector Strategy of Sindh Province. The Technical Resource Facility, Islamabad. Available: www.healthkp.gov.pk/downloads/HSSA-KP.pdf. Accessed 13 Nov. 2011.
35. World Health Organization (2011). Regional Health Systems Observatory- EMRO. World Health Organization.
36. Nishtar S. (2010) Choked pipes: reforming Pakistan's mixed health system. Oxford University Press Karachi. 158 p.
37. Morris J, Stevens P. (2006) Counterfeit medicines in less developed countries. Problems and solutions. International Policy Network, London. Available: http://counterfeiting.unicri.it/docs/Ctf%20medicines%20in%20less%20developed%20countries.pdf Accessed 12 Jan 2011.
38. TRF. (2010) Third-Party Evaluation of the PPHI in Pakistan. Findings, Conclusions and. Recommendations. The Technical Resource Facility, Islamabad. Available: www.trfpakistan.org/LinkClick.aspx?fileticket.tabid = 2404. Accessed: 15 Oct 2011.
39. Bukhari SK, Qureshi JA, Jooma R, Bile KM, Kazi GN, et al. (2010) Essential medicines management during emergencies in Pakistan. East Mediterr Health J 16Suppl: S106-113.
40. Azhar S, Hassali MA, Ibrahim MI, Ahmad M, Masood I, et al. (2009) The role of pharmacists in developing countries: the current scenario in Pakistan. Hum Resour Health, 7: p. 54.
41. Rashidian A, Zaidi S, Jabbour S, Soleymani F, Jahanmehr N. (2011) Identification of priority policy Research Questions in the area of Access to and Use of Medicines in EMRO Countries. Tehran University of Medical Sciences.
42. Selvaraj S, Hasan H, Kumar P, Chokshi M. (2011) Access to Medicines in India: Setting priorities in policy Research Issues. Public Health Foundation of India, India. Available: http://www.who.int/alliance-hpsr/resources/publications/en/index.html. Accessed: 15 June 2012.
43. Nguyen TKC (2011) Identification of priority policy research questions in the area of access to and use of medicines in Viet Nam. Hanoi Medical University, Viet Nam. Available: http://www.who.int/alliance-hpsr/projects/medicines/en/index1.html. Accessed 12 June 2012.
44. Arhinful DK, A Kusi, D Ankrah, W Sackey. (2011). Identification of priority policy research questions in the area of access to and use of medicines in Ghana. Noguchi Memorial Institute. Available: http://www.who.int/alliance-hpsr/projects/noguchighana_medicines/en/index.html. Accessed 11 July 2011.
45. Ntaganira JV, Ndahindwa (2011) Identification des questions de recherché prioritairessur la politiquedans le domaine de l'accès au médicament au Rwanda. National University of Rwanda, Kigali, Rwanda.
46. Ntsama Essomba C, JB Makoko, J Ndong Ekorezock, K Guirsimi and Tiwoda C. (2011) Identification des questions de rechercheprioritaires en matière de politiqued'accèsetd'usage des médicamentsdans des pays francophonesd'AfriqueCentrale, à revenusfaiblesouintermédiaires. Synthèserégionale. Université des Sciences, Yaoundé, Cameroun.
47. Luiza VL, IC Emmerick, TB Axaredo, MA Oliveira, GC Zuluaga, et al. (2011). Identification of priority policy research questions on access to medicines in low- and middle- income countries in Latin America and Caribbean (LAC). Fiocruz National Institute of Public Health, Rio de Janeiro, Brazil. Available: http://www.who.int/alliance-hpsr/projects/oswaldocruz_medicines/en/index.html. Accessed 11 December 2012.
48. Syhakhang L, Manithip C, Sounantha S, Keohavong B. (2011) Identification of Priority Policy Research Questions in the Area of Access to and Use of Medicines in Lao PDR. Available: http://www.who.int/alliance-hpsr/projects/alliancehpsr_laoatmps.pdf. Accessed 11 December 2012.
49. Patouillard E, Goodman CA, Hanson KG, Mills AJ. (2007) Can working with the private for- profit sector improve utilization of quality health services by the poor? A systematic review of the literature. Int J Equity Health, 6: 17 Available: http://www.equityhealthj.com/content/6/1/17. Accessed 22 December 2012.
50. Le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. (1999) Intervention research in rational use of drugs: a review. Health Policy Plan, 14: 89-102. Available: http://archives.who.int/PRDUC2004/Resource_Mats/intervention%20research%20in%20rational%20use%20of%20drugs.pdf. Accessed 22 December 2012.
51. Working Group on Priority Setting. (2000) Priority setting for health research: lessons from developing countries. Health policy and planning, 15 (2): 130-6. Available: http://heapol.oxfordjournals.org/content/15/2/130.abstract. Accessed 10 December 2012.
52. Ranson M, Bennett S. (2009) Priority setting and health policy and system research. Health Policy Syst, 7: 27. Available: http://www.health-policy-systems.com/content/7/1/27. Accessed 15 December 2012.
53. Ranson MK, Chopra M, Atkins S, Dal Poz MR, Bennett S. (2010) Priorities for research into human resources for health in low- and middle-income countries. Bull World Health Organ, 88: 435-443. Available: http://www.who.int/bulletin/volumes/88/6/09-066290/en/. Accessed 29 December 2012.
54. De Savigny, Adam T. (2009) Systems Thinking for Health Systems Strengthening. Alliance for Health Policy and Systems Research, World Health Organization, Geneva. Available: http://apps.who.int/iris/bitstream/10665/44204/1/9789241563895_eng.pdf. Accessed 09 December 2012.
55. Zaidi S, Nishtar N (2013). Rational Prescription & Use: A Snapshot of the Evidence from Pakistan and Emerging Concerns. Int J Pharm Sci, 62-77/2012, Vol 5 (1).
56. El-Jardali F, Makhoul J, Jamal D, Ranson MK, Kronfol NM, et al. (2009) Eliciting policymakers' and stakeholders' opinions to help shape health system research priorities in the Middle East and North Africa region. Health Policy Plan 25: 15-27.